Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
479 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07835893 | Lenvatinib Plus Chemotherapy for pNET Liver Metastases(LEN-pNET) | recruiting | Phase 2 | 80 | Peking Union Medical College HospitalOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT07835906 | 68Ga-NYM215 in NENs | not yet recruiting | Phase 1 / Phase 2 | 40 | Peking Union Medical College HospitalOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT06411678 | Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer | recruiting | Early Phase 1 | 50 | Peking Union Medical College HospitalOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT07200141 | Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer(SIB-NCRT) | recruiting | Phase 2 | 156 | Peking Union Medical College HospitalOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT07822347 | Research on NI-FAPI-04 for the Treatment of Hypoxic and Fibroblast Activation Protein Related Tumors | enrolling by invitation | Phase 1 / Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT07808879 | Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization(HBED-CC-PEG6-E) | recruiting | N/A | 20 | Peking Union Medical College HospitalOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT06973811 | ZR-MTX for PIOL Phase II Trial(ZR-MTX) | recruiting | Phase 2 | 47 | Peking Union Medical College HospitalOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT05559645 | Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)(WU-KONG15) | recruiting | N/A | 180 | Peking Union Medical College HospitalOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT07719959 | A Randomized Controlled Trial of 3D Airway Reconstruction for Precise Double-Lumen Bronchial Intubation | recruiting | N/A | 174 | Peking Union Medical College HospitalOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT07754890 | Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma | recruiting | Phase 1 / Phase 2 | 65 | Peking Union Medical College HospitalOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07761169 | Randomized Controlled Trial of the SurgDiff Model for Predicting Surgical Difficulty to Help Choose Approach in Mid-Low Rectal Cancer | not yet recruiting | N/A | 68 | Peking Union Medical College HospitalOTHER | 0 | Aug 12, 2026 | clinicaltrials |
| NCT07159204 | Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer(PILOT-BTC) | active not recruiting | Phase 2 | 61 | Peking Union Medical College HospitalOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT07738757 | SKB264 Plus KL-A167 in MSI-H/dMMR Advanced Gynecological Malignancies | not yet recruiting | Phase 2 | 80 | Peking Union Medical College HospitalOTHER | 1 | Jul 31, 2026 | clinicaltrials |
| NCT05599789 | Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004)(KeyPemls-004) | active not recruiting | Phase 2 | 47 | Peking Union Medical College HospitalOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT06215677 | Neoadjuvant Immunotherapy for T4 dMMR Colon Cancer(NITDC) | active not recruiting | Phase 2 | 18 | Peking Union Medical College HospitalOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT07704177 | Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract Cancer | recruiting | Phase 2 | 70 | Peking Union Medical College HospitalOTHER | 1 | Jul 15, 2026 | clinicaltrials |
| NCT05507112 | TIME in Immunotherapy Combined With nCRT for Rectal Cancer(TIMENT-R) | active not recruiting | Phase 2 | 100 | Peking Union Medical College HospitalOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT07679399 | A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer. | recruiting | Phase 2 | 222 | Peking Union Medical College HospitalOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT07670273 | Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib as First-Line Therapy for Advanced HER2-Positive/HER2-Low Biliary Tract Cancer | recruiting | Phase 2 | 70 | Peking Union Medical College HospitalOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT07670286 | Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia | recruiting | — | 500 | Peking Union Medical College HospitalOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT07634497 | HAL-PDT for Cervical Intraepithelial Neoplasia Grade 2 | not yet recruiting | — | 500 | Peking Union Medical College HospitalOTHER | 0 | Jun 16, 2026 | clinicaltrials |
| NCT07640048 | Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study | recruiting | — | 90 | Peking Union Medical College HospitalOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT05682950 | Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer | completed | Phase 2 | 15 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT05869123 | Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer | active not recruiting | Phase 1 / Phase 2 | 17 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT05880485 | Online Adaptive Radiotherapy Cervical Cancer With Reduced Margin for Cervical Cancer | active not recruiting | Phase 1 / Phase 2 | 30 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT07625904 | Effects of a Five-Dimensional Intervention Program Based on Inner Strength on Demoralization Syndrome in Elderly Cancer Patients | completed | N/A | 66 | Peking Union Medical College HospitalOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT06949215 | 68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision(NYCRCCL) | recruiting | Phase 2 | 70 | Peking Union Medical College HospitalOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT07590336 | 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma(NYHCC) | not yet recruiting | Phase 1 / Phase 2 | 100 | Peking Union Medical College HospitalOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07578623 | The Impact of Myomectomy on IVF Outcomes: A Multicenter Randomized Controlled Trial(MIO) | not yet recruiting | N/A | 792 | Peking Union Medical College HospitalOTHER | 0 | May 11, 2026 | clinicaltrials |
| NCT07014150 | Neoadjuvant Therapy of Iparomlimab and Tuvonralimab Combined With Lenvatinib for Hepatocellular Carcinoma | recruiting | Phase 2 | 33 | Peking Union Medical College HospitalOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07553793 | Chimeric Antigen Receptor Macrophages Targeting c-MET for Advanced Stage of Pancreatic Cancer Patients | not yet recruiting | Phase 1 | 18 | Peking Union Medical College HospitalOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT07000344 | A Study of Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP Inhibitor | terminated | N/A | 5 | Peking Union Medical College HospitalOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT07516275 | Prospective Cohort Study of Pheochromocytoma/Paraganglioma | not yet recruiting | — | 200 | Peking Union Medical College HospitalOTHER | 0 | Apr 7, 2026 | clinicaltrials |
| NCT05617872 | Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound | completed | N/A | 75 | Peking Union Medical College HospitalOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT07500428 | Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models(BUST-AI Bench) | recruiting | — | 1,380 | Peking Union Medical College HospitalOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT06481826 | Glofitamab in Chinese Patients With R/R DLBCL | recruiting | — | 20 | Peking Union Medical College HospitalOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06836869 | Modified Tumor-free Techniques Operation to Cervical Cancer(MOTTO) | recruiting | N/A | 524 | Peking Union Medical College HospitalOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07498920 | Gut Microbiome in DLBCL Treated With Glofitamab | not yet recruiting | — | 30 | Peking Union Medical College HospitalOTHER | 0 | Mar 27, 2026 | clinicaltrials |
| NCT05514327 | A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL | recruiting | N/A | 20 | Peking Union Medical College HospitalOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT06568705 | Hypofractionated Online Adaptive Radiotherapy of Breast Cancer | recruiting | Phase 2 | 40 | Peking Union Medical College HospitalOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT07464132 | Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases | recruiting | Phase 1 / Phase 2 | 30 | Peking Union Medical College HospitalOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT07453342 | Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge | recruiting | — | 500 | Peking Union Medical College HospitalOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT07452003 | An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC | recruiting | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT07437859 | Exploring the Application of 3D Bioprinting for Personalized Treatment in Primary Liver Cancer With Tumor Microenvironment | active not recruiting | — | 60 | Peking Union Medical College HospitalOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07400224 | Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease | recruiting | Phase 1 / Phase 2 | 600 | Peking Union Medical College HospitalOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT05139095 | Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia | recruiting | Phase 2 | 70 | Peking Union Medical College HospitalOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07381582 | Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(161Tb-LNC1011) | not yet recruiting | Early Phase 1 | 15 | Peking Union Medical College HospitalOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07366099 | Al18F-NOTA-LM3 PET/CT in Patients With TIO | recruiting | N/A | 40 | Peking Union Medical College HospitalOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT07353554 | Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma | not yet recruiting | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT07334535 | Isa-VRD in TIE HRMM | not yet recruiting | Phase 4 | 117 | Peking Union Medical College HospitalOTHER | 1 | Jan 13, 2026 | clinicaltrials |
Data updated 5 days agoSource updated unknownsource: clinicaltrials